A Study of LY2484595 on Pharmacokinetics in Healthy Participants

NCT01448824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: LY2484595
DRUG: Placebo
DRUG: Ketoconazole

Sponsor

Eli Lilly and Company